XT
CTSO icon

XTX Topco’s Cytosorbents Corp CTSO Stock Holding History

XTX Topco’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.3K Buy
54,316
+18,746
+53% +$9.9K ﹤0.01% 3905
2026
Q1 		$20.1K Buy
35,570
+5,888
+20% +$4.02K ﹤0.01% 3548
2025
Q4 		$19K Buy
+29,682
New +$22.8K ﹤0.01% 3069
2025
Q2 		– Sell
-30,113
Closed -$30.1K – 2502
2025
Q1 		$30.1K Buy
30,113
+7,321
+32% +$7.71K ﹤0.01% 2082
2024
Q4 		$20.7K Buy
22,792
+7,840
+52% +$7.69K ﹤0.01% 2031
2024
Q3 		$22.4K Buy
+14,952
New +$16.4K ﹤0.01% 1823

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

XTX Topco's CTSO Position: Q2 2026 in Review

XTX Topco increased its Cytosorbents Corp (CTSO) stake by 53% in Q2 2026, buying an estimated $9.9K and bringing the position to 54,316 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3905.

XTX Topco first reported a position in CTSO in Q3 2024 and has held it in 6 quarters since. The position peaked at $30.1K in Q1 2025. 51 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • XTX Topco held 54,316 shares of Cytosorbents Corp worth $20.3K as of Q2 2026.
  • XTX Topco bought 18,746 Cytosorbents Corp shares in Q2 2026, an estimated $9.9K.
  • Cytosorbents Corp made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3905 holding.
  • XTX Topco first reported a position in Cytosorbents Corp in Q3 2024 and has held it in 6 quarters since.
  • XTX Topco's Cytosorbents Corp position peaked at $30.1K in Q1 2025.
  • 51 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.